Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YiKangNing in Tardive Dyskinesia
NCT00672373Phase 3Completed
- Sponsor
- Peking University Huilongguan Hospital
- Start
- Dec 2006
- Primary completion
- May 2007
- Modality
- HM (Herbal Medicine), TCM (Traditional Chinese Medicine)
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in tardive dyskinesia (TD) comparing YiKangNing with Placebo (2 arms). Primary endpoint: Abnormal Involuntary Movement Scale at 12 weeks. Started Dec 2006; status: completed.
02
Drugs
Yikangning
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT00672373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00672373.